121 related articles for article (PubMed ID: 219564)
21. [Herpes and HIV infection in hemophilic subjects].
Musso A; Riva C; Valpreda A; Perugini L; Negro F; Migliore G
Minerva Pediatr; 1988 Nov; 40(11):621-4. PubMed ID: 2854606
[No Abstract] [Full Text] [Related]
22. Acute hepatitis due to Epstein-Barr virus with cross-reacting antibodies to cytomegalovirus.
Karadeniz A; Yesilbag Z; Kaya FÖ; Akgün FS
Indian J Med Microbiol; 2018; 36(1):143-144. PubMed ID: 29735847
[TBL] [Abstract][Full Text] [Related]
23. The stimulation of immune antibodies anti-A and anti-B in patients after treatment with cryprecipitate and factor IX concentrate (P.P.S.B. according to Soulier).
McShine RL; Kunst VA
Vox Sang; 1970 May; 18(5):435-40. PubMed ID: 5311511
[No Abstract] [Full Text] [Related]
24. Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV).
Sharp RA; Morley SM; Beck JS; Urquhart GE
J Clin Pathol; 1987 Aug; 40(8):849-52. PubMed ID: 3498742
[TBL] [Abstract][Full Text] [Related]
25. [Serological markers of hepatitis B virus and cytomegalovirus in patients with hemophilia].
Kacperska E; Głoskowska-Moraczewska Z; Seyfried H; Kolasińska-Kramer M; Cetnarowicz H; Lopaciuk S
Acta Haematol Pol; 1990; 21(1):52-9. PubMed ID: 2175533
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive care for hemophilia patients in south and west Texas.
Zeltzer PM; LeBaron S; Zeltzer L; Yoken C
Tex Med; 1988 May; 84(5):45-50. PubMed ID: 3261458
[No Abstract] [Full Text] [Related]
27. Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
Funk M; Ebener U; Kreuz W; Ehrenforth S
Lancet; 1993 Oct; 342(8876):933-4. PubMed ID: 7692198
[No Abstract] [Full Text] [Related]
28. Management of the hereditary coagulation disorders.
Mason DY; Ingram GI
Semin Hematol; 1971 Apr; 8(2):158-88. PubMed ID: 5313347
[No Abstract] [Full Text] [Related]
29. Transfusion-related short-incubation hepatitis in hemophilic patients.
Hruby MA; Schauf V
JAMA; 1978 Sep; 240(13):1355-7. PubMed ID: 210302
[TBL] [Abstract][Full Text] [Related]
30. Serum immunoglobulins in patients with congenital coagulation defects and their relatives.
Mingers AM; Mietens C; Ströder J
Z Kinderheilkd; 1971; 109(3):199-210. PubMed ID: 5313318
[No Abstract] [Full Text] [Related]
31. Transfusion-associated hepatitis not due to viral hepatitis type A or B.
Feinstone SM; Kapikian AZ; Purcell RH; Alter HJ; Holland PV
N Engl J Med; 1975 Apr; 292(15):767-70. PubMed ID: 163436
[TBL] [Abstract][Full Text] [Related]
32. Post-transfusion hepatitis in a London hospital: results of a two-year prospective study. A report to the M.R.C. Blood Transfusion Research Committee by the Medical Research Council Working Party on Post-Transfusion Hepatitis.
J Hyg (Lond); 1974 Oct; 73(2):173-88. PubMed ID: 4370614
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease.
Langenhuysen MM; Cazemier T; Houwen B; Brouwers TM; Halie MR; The TH; Nieweg HO
Cancer; 1974 Aug; 34(2):262-7. PubMed ID: 4368421
[No Abstract] [Full Text] [Related]
34. [Treatment of hemophilias].
Fischer M; Deutsch E
Dtsch Med J; 1968 Jul; 19(14):499-505. PubMed ID: 5305713
[No Abstract] [Full Text] [Related]
35. Effect of circulating immune complexes on transfusional therapy in patients with hemophilia or von Willebrand's disease.
Celada A; Aguado MT; Maire M; Ortega F; Magallon M; Martin-Villar J; Lambert PH
Transfusion; 1984; 24(1):46-52. PubMed ID: 6420954
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antibodies to Epstein-Barr virus, cytomegalovirus and Toxoplasma in a Mexican highland community.
Golubjatnikov R; Allen VD; Steadman M; Del Pilar Olmos Blanc ; Inhorn SL
Am J Epidemiol; 1973 Feb; 97(2):116-24. PubMed ID: 4347509
[No Abstract] [Full Text] [Related]
37. Prospective Evaluation of Non-Compliant Severe Hemophilia Patients.
Uğur MC; Kavaklı K
Turk J Haematol; 2019 May; 36(2):137-138. PubMed ID: 30277465
[No Abstract] [Full Text] [Related]
38. Immunization of haemophiliacs against hepatitis B. A joint study between the haemophilia centers in Leuven, Belgium and Malmö, Sweden.
Hedner U; Hansson BG; Vermylen J; Verstraete M; Colaert J; Desmyter J
Scand J Haematol Suppl; 1984; 40():317-21. PubMed ID: 6236549
[No Abstract] [Full Text] [Related]
39. Immunologic investigation of Chinese hemophiliacs with and without human immunodeficiency virus infection.
Tang DJ; Pang XG
Chin Med J (Engl); 1991 Oct; 104(10):803-7. PubMed ID: 1752140
[TBL] [Abstract][Full Text] [Related]
40. Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates.
Hanley JP; Jarvis LM; Hayes PC; Lee AJ; Simmonds P; Ludlam CA
Thromb Haemost; 1998 Feb; 79(2):291-5. PubMed ID: 9493578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
